Page last updated: 2024-09-03

galactosyl-(1-3)galactose and HPV Infection

galactosyl-(1-3)galactose has been researched along with HPV Infection in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Avila, JL; Hernández, D; Rojas, M; Teixeira, GM; Tremont-Lukats, IW; Vásquez, J1
Avila, JL; Cáceres-Dittmar, G; Hernández, D; Rojas, M; Tapia, F; Tremont-Lukats, IW1
Cohen, A; Correnti, M; Fisher, D; Harner, R; Hernàndez, DE1

Other Studies

3 other study(ies) available for galactosyl-(1-3)galactose and HPV Infection

ArticleYear
Antibody levels against alpha-galactosyl epitopes in sera of patients with squamous intraepithelial lesions and early invasive cervical carcinoma.
    Gynecologic oncology, 1997, Volume: 64, Issue:2

    Topics: Adult; Analysis of Variance; Antibodies; Carcinoma in Situ; Carcinoma, Squamous Cell; Disaccharides; Epitopes; Female; Humans; Neoplasm Invasiveness; Papillomaviridae; Papillomavirus Infections; Prospective Studies; Tumor Virus Infections; Uterine Cervical Neoplasms

1997
Abnormal expression of galactosyl(alpha 1-->3) galactose epitopes in squamous cells of the uterine cervix infected by human papillomavirus.
    Pathobiology : journal of immunopathology, molecular and cellular biology, 1996, Volume: 64, Issue:5

    Topics: Adolescent; Adult; Carcinoma, Squamous Cell; Cervix Uteri; Disaccharides; Epithelium; Epitopes; Female; Humans; Male; Middle Aged; Papillomaviridae; Papillomavirus Infections; Tumor Virus Infections; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms

1996
Antibody levels against galactosyl (alpha1 --> 3) galactose epitopes in cervical mucus from patients with human papillomavirus infection.
    Gynecologic oncology, 2002, Volume: 84, Issue:3

    Topics: Adolescent; Adult; Cervix Mucus; Disaccharides; Female; Humans; Immunoglobulin G; Nucleic Acid Hybridization; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Risk Factors; Tumor Virus Infections; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms

2002